Contineum Therapeutics Ratios (2023-2026) | CTNM

Ratios Mar2023 Jun2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) 84.60%
EBIT Margin (Quarter) 77.87%
EBITDA Margin (Quarter) 77.87%
Operating Margin (Quarter) 77.87%
Net Margin (Quarter) 83.14%
FCF Margin (Quarter) 81.41%
Efficiency
Assets Average (Quarter) 126.97M172.46M218.69M214.44M205.56M190.58M186.87M233.74M269.00M
Asset Utilization Ratio (Quarter) 0.29
Leverage & Solvency
Interest Coverage Ratio (Quarter) -55.60335.66-0.37-135.29-3.06-6.16-0.75-20.06-0.70
Times Interest Earned (Quarter) -55.60335.66-0.37-135.29-3.06-6.16-0.75-20.06-0.70
Valuation
Enterprise Value (Quarter) -125.19M-117.91M-218.65M-213.91M-204.76M-190.71M-175.48M-182.41M-262.90M-246.33M
Return Ratios
Return on Sales (Quarter) 0.01%-0.01%
Return on Capital Employed (Quarter) 9.33%-22.89%-20.44%-24.89%-30.05%-36.01%-37.67%-30.38%-25.48%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%